Q2 2026 13F · SEC CIK 939219
Lee Danner & Bass Inc
Wealth managerFiled 2026-07-21 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $1.7B
- Reported positions
- 250
- Top holdings a year, 3 yrs
- +18.8%
- Assets under management
- $2.0B
Lee Danner & Bass Inc is a wealth manager that reported 250 positions worth $1.7B in its Q2 2026 13F, filed 2026-07-21. Its largest holdings were HCA Healthcare Inc (HCA, 8.8%), Berkshire Hathaway Inc Del (BRK-B, 7.5%), Viasat Inc (VSAT, 4.3%). A portfolio copying its top holdings returned 18.8% a year over the last 3 years, against 20.4% for the S&P 500.
Lee Danner & Bass Inc holdings largest 50 of 250 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Lee Danner & Bass Inc bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- MDT Medtronic PLC+16.7% shares
- ORCL Oracle Corp+10.3% shares
- ACN Accenture PLC Ireland Shs Class A+6.6% shares
Reduced
- L Loews Corp-10.7% shares
- CAT Caterpillar Inc Com-6.5% shares
Left the top 50
- XOM Exxon Mobil Corpwas 1.6%
- AGI Alamos Gold Incwas 0.7%
- HON Honeywell Intl Incwas 0.6%
- AMGN Amgen Inc Comwas 0.5%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +20.1% /yr
- S&P 500 +20.1%
- 3 years
- +18.8% /yr
- S&P 500 +20.4%
- 5 years
- +13.3% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $1.7B | 250 |
| Q1 2026 | $1.6B | 246 |
| Q4 2025 | $1.4B | 234 |
| Q3 2025 | $1.4B | 233 |
| Q2 2025 | $1.3B | 223 |
| Q1 2025 | $1.2B | 220 |
| Q4 2024 | $1.3B | 745 |
| Q3 2024 | $1.4B | 220 |
| Q2 2024 | $1.3B | 211 |
| Q4 2023 | $1.2B | 205 |
| Q3 2023 | $1.1B | 199 |
| Q2 2023 | $1.2B | 204 |
Questions about Lee Danner & Bass Inc's portfolio
What stocks does Lee Danner & Bass Inc own?
Lee Danner & Bass Inc's latest 13F, for Q2 2026 and filed Jul 21, 2026, lists 250 positions worth $1.7B. The largest are HCA Healthcare Inc (HCA) at 8.8%, Berkshire Hathaway Inc Del (BRK-B) at 7.5%, Viasat Inc (VSAT) at 4.3%, Alphabet Inc (GOOG) at 4.0% and Corecivic Inc (CXW) at 3.8%.
What did Lee Danner & Bass Inc buy last quarter?
In Q2 2026, Lee Danner & Bass Inc added Medtronic PLC (MDT) (+16.7% shares), Oracle Corp (ORCL) (+10.3% shares) and Accenture PLC Ireland Shs Class A (ACN) (+6.6% shares), compared with its Q1 2026 filing.
What did Lee Danner & Bass Inc sell last quarter?
In Q2 2026, Lee Danner & Bass Inc cut from its top 50 Exxon Mobil Corp (XOM), cut from its top 50 Alamos Gold Inc (AGI), cut from its top 50 Honeywell Intl Inc (HON), cut from its top 50 Amgen Inc Com (AMGN), Loews Corp (L) (-10.7% shares) and Caterpillar Inc Com (CAT) (-6.5% shares), compared with its Q1 2026 filing.
How has Lee Danner & Bass Inc's portfolio performed?
A portfolio copying Lee Danner & Bass Inc's 20 largest 13F holdings each quarter, from the day each filing was public, returned +18.8% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +20.1% against +20.1%. Over 5 years: +13.3% a year against +11.6%.
When is Lee Danner & Bass Inc's next 13F filing due?
13F filings are due 45 days after each quarter ends. Lee Danner & Bass Inc's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Lee Danner & Bass Inc manage?
Lee Danner & Bass Inc reported $2.0B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $1.7B.